# Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC

> **NCT03897946** · PHASE4 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 569 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** Birth dose hepatitis B vaccine

## Key facts

- **NCT ID:** NCT03897946
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-20
- **Primary completion:** 2021-02-05
- **Final completion:** 2021-02-05
- **Target enrollment:** 569 (ACTUAL)
- **Last updated:** 2021-03-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03897946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03897946, "Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03897946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*